Using machine-learning techniques to analyze functional imaging data, a team of Foundation-supported researchers reports that it was able to identify the presence of schizophrenia in 78 percent of a…
Read More
New data gleaned from learning-task experiments and fMRI imaging of young adults at clinical high risk for psychosis support the theory that problems in a particular brain circuit contribute to the…
Read More
New research in mice reveals how THC, the main psychoactive compound in cannabis, can reduce the effectiveness of risperidone, an antipsychotic drug used widely to treat people with schizophrenia.…
Read More
In response to a 1996 government mandate, food producers in the U.S. began fortifying their grain-based products with folic acid to reduce serious birth defects affecting the brain, spinal cord, and…
Read More
Genetic Variations Reveal Which Patients Will Have Cognitive Benefits From Antipsychotic Medications
Antipsychotic medications are a cornerstone of treatment for schizophrenia and related disorders. They prevent hallucinations and delusions for most people, and for some, they also help reduce the…
Read More
